Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name PI Organization Sort descending Title Grant Number Program Official
Mehta, Anand S.

Medical University Of South Carolina
United States

Glycan Biomarkers for Cholangiocarcinoma 5R01CA289381-02 Sidney Fu, M.D.
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-11 Nicholas Hodges, Ph.D.
Kisiel, John

Mayo Clinic Rochester
United States

Multi-cancer Early Detection 2R01CA214679-08 Matthew Young, Ph.D.
Fabian, Carol J.

University Of Kansas Medical Center
United States

Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer 5R01CA249437-05 Edward Sauter, M.D., Ph.D.
Upshaw, Jenica

Beth Israel Deaconess Medical Center
United States

A randomized trial of cardioprotective strategies in newly diagnosed diffuse large B-cell lymphoma and pre-existing cardiomyopathy or prior anthracycline exposure 1R37CA300969-01 Eileen Dimond, R.N., M.S.
Baghdadi, Tareq Al

Saint Joseph Mercy Health System
United States

Michigan Cancer Research Consortium NCORP 3UG1CA189971-11S1 Vanessa A. White, M.P.H.
Onitilo, Adedayo A

Marshfield Clinic, Inc.
United States

Wisconsin NCI Community Oncology Research Program (WiNCORP) 3UG1CA189956-11S1 Vanessa A. White, M.P.H.
Rajagopalan, Malolan S

Columbus Community Clinical Oncology Prg
United States

Columbus NCORP RFA-CA-18-016 3UG1CA189954-11S1 Vanessa A. White, M.P.H.
Hur, Chin

Columbia University Health Sciences
United States

Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype 3R01CA257333-05S1 Matthew Young, Ph.D.
Kahalley, Lisa Schum

Baylor College Of Medicine
United States

Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy. 3R01CA249988-05S3 Rachel Altshuler, Ph.D.